ExploreConditionCardiometabolic Risk Factors
Condition

Cardiometabolic Risk Factors

Also known as: Cardiometabolic Risk Factor Cardiometabolic Risk Factors Factor, Cardiometabolic Risk Factors, Cardiometabolic Risk Risk Factor, Cardiometabolic Risk Factors, Cardiometabolic cardiometabolic risk
12 findings 1 paper 6 related entities View in graph →

Related entities

interventions
outcomes
populations
studys

Findings (50)

None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,
None
null

Physical activity showed a suggestive but non-significant pattern of modifying the PFAS mixture-cardiometabolic association: cardiometabolic risk scores increased by 0.7 units per IQR increase in the

Effect: null; B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS mixture; CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7, 0.7 (high PA)

Size: B: 0.7 (low PA) vs B: 0.0 (high PA) per IQR increase in PFAS CI: 95% CI: 0.0, 1.3 (low PA); 95% CI: −0.7,

Papers (1)